Log In
person
NeoGenomics Inc
NEO
summarize
4 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Advanced Diagnostics |
Contract Clinical Testing Services for Drug Manufacturers
These companies provide contract clinical testing services to pharmaceutical and biotechnology companies. These services can be employed anywhere from early-stage to late-stage drug development. In the process of providing these testing services, the companies gain approval from relevant regulatory agencies.
|
96.01M | 16.23% |
| Clinical Services |
Genetic, Genomic, and Sequencing Diagnostic Services; Self Paid
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
332.08M | 56.13% |
| Clinical Services |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Private Insurance
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
89.21M | 15.08% |
| Clinical Services |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Government Insurance
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from government insurance payer programs.
|
74.35M | 12.57% |
| keyboard_arrow_down |
Advanced Diagnostics
Contract Clinical Testing Services for Drug Manufacturers
|
96.01M | 16.23% |
| keyboard_arrow_right |
These companies provide contract clinical testing services to pharmaceutical and biotechnology companies. These services can be employed anywhere from early-stage to late-stage drug development. In the process of providing these testing services, the companies gain approval from relevant regulatory agencies.
|
||
| keyboard_arrow_down |
Clinical Services
Genetic, Genomic, and Sequencing Diagnostic Services; Self Paid
|
332.08M | 56.13% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from patient ''self-pay''.
|
||
| keyboard_arrow_down |
Clinical Services
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Private Insurance
|
89.21M | 15.08% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
||
| keyboard_arrow_down |
Clinical Services
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Government Insurance
|
74.35M | 12.57% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from government insurance payer programs.
|
||